Published in J Clin Oncol on April 29, 2009
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract (2013) 1.48
Global ovarian cancer health disparities. Gynecol Oncol (2012) 1.24
Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol (2014) 1.19
Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer (2011) 1.18
Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. Br J Cancer (2012) 1.15
Geographic proximity and racial disparities in cancer clinical trial participation. J Natl Compr Canc Netw (2010) 1.03
Variation in question asking during cancer clinical interactions: a potential source of disparities in access to information. Patient Educ Couns (2010) 1.00
Residential racial composition, spatial access to care, and breast cancer mortality among women in Georgia. J Urban Health (2011) 1.00
Are depressive symptoms more common among British South Asian patients compared with British White patients with cancer? A cross-sectional survey. BMJ Open (2013) 0.93
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap. BJU Int (2010) 0.92
Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis. Arthritis Rheum (2009) 0.89
Health-Related Quality of Life of Young Adult Survivors of Childhood Cancer: A Review of Qualitative Studies. J Adolesc Young Adult Oncol (2011) 0.87
Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differences. Patient Educ Couns (2014) 0.86
A mixed-methods examination of communication between oncologists and primary care providers among primary care physicians in underserved communities. Cancer (2014) 0.84
Implementing cancer prevention into clinical practice. J Cancer Educ (2012) 0.83
Racial differences in surgeons and hospitals for endometrial cancer treatment. Med Care (2011) 0.83
Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Cancer (2010) 0.80
Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes. J Clin Oncol (2009) 0.79
Slow progress in cancer care disparities: HIPAA, PPACA, and CHEWBACCA... but we're still not there! Oncologist (2011) 0.78
Culturally and linguistically diverse patient participation in glioma research. Neurooncol Pract (2014) 0.78
Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer. Cancer (2015) 0.76
A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients. J Racial Ethn Health Disparities (2015) 0.75
ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska. J Oncol Pract (2015) 0.75
Disparities in Gynecological Malignancies. Front Oncol (2016) 0.75
The truth, the whole truth, and the medical record. J Oncol Pract (2009) 0.75
Video intervention increases participation of black breast cancer patients in therapeutic trials. NPJ Breast Cancer (2017) 0.75
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med (2004) 23.44
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res (2008) 14.37
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med (2003) 11.35
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med (2013) 6.17
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol (2011) 5.95
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol (2009) 5.45
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol (2010) 4.93
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol (2013) 4.03
Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the future. Hum Pathol (2009) 3.91
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol (2006) 3.81
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16. J Natl Cancer Inst (2006) 3.63
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol (2011) 3.59
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA (2003) 2.90
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2005) 2.47
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol (2011) 2.30
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol (2008) 2.14
American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol (2013) 2.14
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol (2012) 2.09
Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93
Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med (2005) 1.85
Association of nonmelanoma skin cancer with second malignancy. Cancer (2004) 1.82
Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer (2010) 1.77
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol (2012) 1.76
Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med (2007) 1.75
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75
Palliative care and the quality of life. J Clin Oncol (2011) 1.75
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426). Cancer (2008) 1.73
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2008) 1.69
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2006) 1.64
The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J Psychosom Res (2003) 1.60
Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecol Oncol (2011) 1.55
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2009) 1.53
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract (2013) 1.48
Traditional versus telenursing outpatient management of patients with cancer with new ostomies. Oncol Nurs Forum (2004) 1.45
Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44
Prostate cancer: what did we learn from the 2012 Annual Scientific Meeting of ASCO? Oncology (Williston Park) (2012) 1.43
High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol (2010) 1.37
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol (2009) 1.35
Depression and anxiety in women with breast cancer and their partners. Nurs Res (2006) 1.31
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas (2006) 1.31
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol (2008) 1.29
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2007) 1.28
Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer (2005) 1.23
Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer (2011) 1.18
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial. Gynecol Oncol (2009) 1.18
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol (2004) 1.17
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol (2008) 1.16
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer (2006) 1.16
Breast cancer among Hispanic and non-Hispanic White women in Arizona. J Health Care Poor Underserved (2007) 1.15
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol (2009) 1.14
Interdependent anxiety and psychological distress in women with breast cancer and their partners. Psychooncology (2007) 1.12
Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11
Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause (2007) 1.11
Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev (2009) 1.11
Storytelling for promoting colorectal cancer screening among underserved Latina women: a randomized pilot study. Cancer Control (2009) 1.09
From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08
Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07
Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05
Tobacco cessation and control a decade later: American society of clinical oncology policy statement update. J Clin Oncol (2013) 1.05
Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05
Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life. Oncol Nurs Forum (2005) 1.05
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer (2013) 1.04
Virtual slide telepathology for an academic teaching hospital surgical pathology quality assurance program. Hum Pathol (2009) 1.04
Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort. J Womens Health (Larchmt) (2008) 1.04
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol (2010) 1.02
Cancer-related infertility in survivorship. Int J Gynecol Cancer (2010) 1.01
Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials. Cancer (2009) 1.01
The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.01
Myeloma and race: a review of the literature. Cancer Metastasis Rev (2003) 1.00
The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer (2010) 0.99
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer. Clin Cancer Res (2004) 0.99